Regeneron Schedules December 20, 2010 Teleconference and Webcast to Discuss Results of VEGF Trap-Eye Phase 3 Study in Central Retinal Vein Occlusion (CRVO) and Phase 2 Study in Diabetic Macular Edema (DME) - Drugs.com MedNews
Links shared publicly online about this topic.
- 641total visits
Regeneron Schedules December 20, 2010 Teleconference and Webcast to Discuss Results of VEGF Trap-Eye Phase 3 Study in Central Retinal Vein Occlusion (CRVO) and Phase 2 Study in Diabetic Macular Edema (DME) - Drugs.com MedNews
TARRYTOWN, N.Y., Dec. 20, 2010 PRNewswire-FirstCall Regeneron Pharmaceuticals, Inc. (Nasdaq REGN) today announced that it will hold a teleconference and webcast
View full resource at drugs.com
Tags: Circulation, Edema, Diabetes, Drug, Pharma, Phase 2 Clinical Trial, Phase 3 Clinical Trial
Most Recently Shared on December 20, 2010 at 9:07 pm By:
Regeneron Schedules December 20, 2010 Teleconference and Webcast to Discuss Results of VEGF Trap-Eye Phase... http://bit.ly/gz434x #drug
Advertisement
